Vor Biopharma IncVOR
Price$19.34

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $0TTM through 31 Mar 2026
Net Income -$883.1MTTM through 31 Mar 2026
Free Cash Flow -$150.7MTTM through 31 Mar 2026

Margins

Current

Returns

N/A (negative equity)ROE
-43.3%ROA

Balance Sheet Health

Debt / EquityN/A (negative equity)
Current Ratio31.15x
Net Debt-$488.6Mnet cash position
Cash & Equivalents$491.5M

Quality Metrics

Earnings-Beat Rate50.0%

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.